TL;DR: Pando Bioscience is a Y Combinator Winter 2023 startup Gen-AI Designed Enzymes for Pharmaceutical Innovation, currently active with a team of 5.
Gen-AI Designed Enzymes for Pharmaceutical Innovation
Last verified:
Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our generative AI to efficiently optimize enzymes across multiple properties, delivering high-performing, tailored enzymes that reduce costs and enhance efficiency.
Built by LemStudio
Yes. Pando Bioscience was funded by Y Combinator in the Winter 2023 batch. Gen-AI Designed Enzymes for Pharmaceutical Innovation
Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our generative AI to efficiently optimize enzymes across mul…
Pando Bioscience was part of Y Combinator's Winter 2023 batch.
Pando Bioscience has a team of 5 people according to Y Combinator's directory.
Pando Bioscience is currently listed as Active with a team of 5 in Y Combinator's directory.
Loading interactive view…